Search Results for 'pat'

Contract Service Directory Companies

View All Buyers Guide Companies »

Contract Service Directory Categories

View All Categories »

• Breaking News | CRO News | Drug Development
  

  Altasciences Chooses Proscia’s Digital Pathology Platform

  To deploy Concentriq for research to unify massive volumes of study data and streamline collaboration among internal and external stakeholders.

  03.21.23
  

  ---

• 

  Identifying Sustainable Pathways Toward Oligonucleotide Therapeutics

  After nearly 50 years of research and development, oligonucleotide therapeutics are starting to make their mark on the pharmaceutical scene.

  ---

• Analytical Services | Bioanalytical Services | Laboratory Testing
  

  Introducing PAT/QbD to Biotech Production

  An insurmountable opportunity?

  Emil W. Ciurczak , DoraMaxx Consulting 03.10.23
  

  ---

• Breaking News | Drug Development | Industry News
  

  BioNxt Begins Drug Absorption Study for Transdermal Rotigotine Patch

  Study to assess the relative bioavailability, skin adhesion and skin tolerance of BioNxt's new formulation compared to the name brand product.

  03.02.23
  

  ---

• Breaking News | Drug Development | Trials & Filings
  

  FDA Approves SKYCLARYS for Patients with Friedreich’s Ataxia

  Rare pediatric disease priority review voucher granted.

  03.02.23
  

  ---

• Drug Development | R&D
  

  Pathways for Successful AI Adoption in Drug Development

  Download the white paper by VeriSIM Life Chief Scientific Officer Dr. Szczepan Baran and Peter Henstock, Machine Learning/AI Lead at Pfizer

  ---

• Clinical Trials | Drug Development | Information Technology
  

  Adopting Data Analytics and Visualizations to Ensure Patient Safety and Improve Data Quality

  How data visualizations, designed intuitively and with interpretation in mind, can boost clinical trial efficiency and patient safety.

  Danielle Grindley, Senior Digital Health Analyst at PHASTAR 02.23.23
  

  ---

• 2023 Patients as Partners in Clinical Research

  ...

  02.06.23
  

  ---

• 

  Vetter Hackathon 2022: innovation booster through employee participation

  Open team approach to develop new pathways for the pharmaceutical service provider

  ---

• SCOPE's Patient Recruitment & Engagement 2023

  ...

  11.17.22
  

  ---

• Breaking News
  

  Syneos Health to Introduce Dedicated HUB Patient Suite

  Combines the company’s advisory, analytics and digitally-enabled capabilities to bring modern, prescription management services to customers.

  10.27.22
  

  ---

• Breaking News | Collaborations & Alliances
  

  Inceptor Bio and Avectas Patner to Improve the Development & Manufacturing of CAR-T Cell Therapies

  Inceptor will utilize Avectas' SOLUPORE technology as an alternative to electroporation for engineering healthier T cells.

  10.12.22
  

  ---

• 

  Operationalizing Patient Centricity:

  Insights and best practices for a new era of drug development

  10.03.22
  

  ---

• cGMP Manufacture | Drug Development | Fill/Finish | R&D
  

  Contract Pharma Sits Down with Patrick Haffey of Selkirk Pharma

  CEO of Fill/Finish CMO shares insight on the future of the Pharmaceutical industry.

  Videos

  ---

• Breaking News | Promotions & Moves
  

  C-Path Names Daniel Jorgensen CEO

  Will continue C-Path's collaboration with global stakeholders, including academic institutions, the pharmaceutical industry and regulatory agencies.

  09.28.22
  

  ---

• Clinical Trials
  

  India Moves to Uphold Patient Safety in Clinical Trials

  Tougher laws on the anvil to curb breach.

  S. Harachand, Contributing Editor 09.07.22
  

  ---

• Aseptic Processing | Fill/Finish | Lyophilization | Parenterals
  

  Why Robotic Sterile Fill-Finish Is Key for Speed to Clinic and Patient Safety

  Sterile fill-finish is a mainstay in pharmaceutical manufacturing and robotic platforms will be a true differentiator.

  Mark Shepanski, PCI Pharma Services 09.07.22
  

  ---

• Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
  

  Cell and Gene R&D in Cancer Care: Increasing Patient Access

  The latest in CAR-T therapies including manufacturing, storage and supply chain, and dose optimization in early phase oncology.

  Online Exclusives David Alsadius, Jeffrey Hodge, and Erin Finot, IQVIA 09.06.22
  

  ---

• Breaking News | Clinical Trials
  

  Avid Bioservices Names Pramthesh Patel as VP, Process Development for Mammalian Cell Business

  Dr. Patel is an accomplished biopharmaceutical industry executive with more than 30 years of experience.

  09.01.22
  

  ---

• Clinical Trial Materials | Clinical Trials | Logistics
  

  The Importance of Patient Centricity in Clinical Research and Cell / Gene Therapy Development

  Patient centricity in the clinical trial community involves meeting the patients where they are.

  ---

• Clinical Trials | Drug Development
  

  Advancing Patient-Focused Innovation in Oncology R&D

  Jeffrey Keefer at IQVIA shares key highlights from ASCO ’22

  Online Exclusives Jeffrey Keefer, Vice President and Head, Hematology/Oncology Center of Excellence, IQVIA 06.13.22
  

  ---

• Biologics, Proteins, Vaccines | Breaking News
  

  Emergex COVID-19 Vaccine Candidate Successfully Coated onto Zosano Micro-Needle Patch

  May allow for less costly and efficient vaccination programs around the world and increase global preparedness for future pandemics.

  05.17.22
  

  ---

• Breaking News | Trials & Filings
  

  FDA Approves Lilly’s OLUMIANT to Treat Certain Hospitalized COVID Patients

  OLUMIANT is the first JAK inhibitor FDA-approved for the treatment of COVID-19 in certain hospitalized adults requiring various degrees of oxygen support.

  05.11.22
  

  ---

• Analytical Services | Bioanalytical Services | R&D
  

  Some Tools to Build A PAT/QbD Program

  This month we look at R&D technology applied to process understanding and control.

  Emil W. Ciurczak, Contributing Writer 04.04.22
  

  ---

• Drug Delivery | Parenterals
  

  Improving Patient Compliance: Trends in Advanced Drug Delivery

  Exploring the key trends affecting the advanced drug delivery segment.

  Nick DiFranco, Market Manager for Long-Acting Drug Delivery and Combination Products, Lubrizol Life Science (LLS) Health 04.04.22
  

  ---

• Breaking News | Drug Development | Trials & Filings
  

  Boehringer's Idiopathic Pulmonary Fibrosis Drug Gets Breakthrough Designation

  Oral, phosphodiesterase 4B (PDE4B) inhibitor has potential to address both pulmonary fibrosis scarring and inflammation.

  02.25.22
  

  ---

• Preclinical Outsourcing | Promotions & Moves
  

  Altasciences Names Wendell Davis VP, Pathology

  Davis brings experience evaluating small molecules, biologics, oligonucleotide, and an array of RNA therapeutics modalities.

  02.08.22
  

  ---

• Breaking News
  

  Lonza Drug Product Services Participates in RealHOPE Project

  Initiative aims to measure real-life events during drug handling that can destabilize protein-based therapeutics.

  01.19.22
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
  

  Roche’s Ronapreve Reduces Viral Load in COVID-19 Patients

  Phase II/III trial met primary endpoint, showing Ronapreve significantly reduced viral load in patients hospitalized with COVID-19.

  09.30.21
  

  ---

• Breaking News | Drug Development | Industry News
  

  Veklury Reduced Risk of Hospitalization in High-Risk COVID-19 Patients

  Veklury demonstrated a statistically significant 87% reduction in risk for the composite primary endpoint of COVID-19 related hospitalization.

  09.22.21
  

  ---

• Breaking News | Clinical Trials
  

  First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy

  TAC01-HER2 was developed for the treatment of HER2-overexpressing cancers.

  09.21.21
  

  ---

• Breaking News | Industry News
  

  Samsung Biologics to Participate in Frontier 1.5D Initiative

  Will develop a climate risk management model as part of 2050 Carbon Neutral Strategy in response to the challenges associated with climate change.

  09.14.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Industry News | Preclinical Outsourcing
  

  Lonza, CN Bio Partner on Prevalidated Hepatocytes for Organ-on-a-chip Range

  Lonza will supply cells to be prequalified for use in CN Bio’s innovative PhysioMimix OOC range of Single- and Multi-Organ Microphysiological Systems.

  07.19.21
  

  ---

• Breaking News | Cytotoxics and High Potency Manufacturing | Industry News | Solid Dosage/Creams/Ointments
  

  Idifarma Launches Accelerated Pathway for Complex Drugs

  ‘Simply to Clinic’ leverages expertise in oral standard and highly potent drugs to take projects from pre-formulation to clinical trials.

  07.14.21
  

  ---

• 

  Patrice Dudley Aviles Joins Abzena as Chief Human Resource Officer

  Aviles offers 25 years’ experience in the pharmaceutical industry.

  06.29.21
  

  ---

• Breaking News | Collaborations & Alliances
  

  Cellenkos Chooses Cryoport to Support Covid-19 Therapy Shipments to Patients

  Cryoport will provide tracking and proactive management for the therapies.

  06.22.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  ProCell for Patient Project to Develop Automated Production Unit for CAR-T Cell Therapies

  Standardized and automated manufacturing aims to reduce the amount of work on producing CAR-T cells by 50 percent.

  06.10.21
  

  ---

• Aseptic Processing | Facilities | Fill/Finish
  

  CEO Spotlight: Patrick Haffey, Selkirk

  The chief executive talks about entering the fill/finish space as a CMO startup and the company’s new aseptic fill/finish facility.

  Tim Wright, Editor, Contract Pharma 06.07.21
  

  ---

• Breaking News | Clinical Trials | CRO News
  

  Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

  Adding layer of technology to HGH treatments aims to facilitate better patient compliance.

  Kristin Brooks 04.08.21
  

  ---

• Breaking News | Industry News | Promotions & Moves
  

  Alcami Names Patrick D. Walsh as Chairman and CEO

  35-year pharmaceutical industry veteran brings deep industry expertise and a track record of building successful, client-centric, growth organizations.

  Tim Wright, Editor, Contract Pharma 03.19.21
  

  ---

• Promotions & Moves
  

  Alcami Appoints Patrick D. Walsh as Chairman and Chief Executive Officer

  He succeeds Walter J. Kaczmarek III, who is stepping down as Chief Executive Officer.

  ---

• Breaking News | Clinical Trials
  

  Strata Oncology Unveils Strata PATH Trial

  The new platform clinical trial will evaluate FDA-approved therapies in novel biomarker profiles learned from real-world data.

  Charles Sternberg, Assistant Editor 03.02.21
  

  ---

• Patients as Partners in Clincial Trials

  ...

  02.17.21
  

  ---

• Breaking News | Clinical Trials | Promotions & Moves
  

  Parexel Appoints Chief Patient Officer

  Demonstrates the company’s commitment to elevating the patient perspective.

  Contract Pharma Staff 01.06.21
  

  ---

• Drug Delivery | Injectables
  

  Self-Medication: Flexibility for Patients and Drug Manufacturers

  Bringing together self-medication with auto-injectors and sustainable secondary packaging.

  Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20
  

  ---

• Breaking News | Collaborations & Alliances | CRO News
  

  PathoQuest, Charles River Expand Strategic Pact

  Establishes a biologics genomic testing laboratory in Wayne, PA to expand next-generation sequencing capabilities.

  Contract Pharma Staff 11.12.20
  

  ---

• 

  Syngene eases clients’ path to drug discovery

  Anil Urs - Bengaluru

  ---

• Breaking News | Clinical Trials
  

  Thermo Fisher Expands Direct-to-Patient Service

  Offering now includes Clinical Site-to-Patient, Pharmacy-to-Patient and Depot-to-Patient services to enable medication delivery directly to patients' homes.

  Contract Pharma Staff 10.27.20
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News
  

  ImmunOs Uses ProBioGen’s Pathway Modulator Technology

  DirectedLuck transposase technology will be used to increase protein yield of selected candidates in their pipeline of complex recombinant proteins.

  Contract Pharma Staff 10.27.20
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
  

  Lilly Pauses ACTIV-3 Clinical Trial in Hospitalized COVID-19 Patients

  ACTIV-3 study is evaluating the efficacy of Lilly’s neutralizing antibody in hospitalized COVID-19 patients, the most advanced stage of the disease.

  Contract Pharma Staff 10.16.20
  

  ---